AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 34 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $39,000 | -11.4% | 16,478 | 0.0% | 0.00% | – |
| Q1 2019 | $44,000 | +18.9% | 16,478 | -2.9% | 0.00% | – |
| Q4 2018 | $37,000 | -26.0% | 16,968 | 0.0% | 0.00% | – |
| Q3 2018 | $50,000 | +11.1% | 16,968 | 0.0% | 0.00% | – |
| Q2 2018 | $45,000 | -85.0% | 16,968 | -20.6% | 0.00% | – |
| Q1 2018 | $301,000 | +50.5% | 21,370 | +25.9% | 0.00% | – |
| Q4 2017 | $200,000 | -39.4% | 16,968 | -27.1% | 0.00% | – |
| Q3 2017 | $330,000 | +0.9% | 23,260 | 0.0% | 0.00% | – |
| Q2 2017 | $327,000 | -1.8% | 23,260 | +16.5% | 0.00% | – |
| Q1 2017 | $333,000 | +0.6% | 19,961 | -0.5% | 0.00% | – |
| Q4 2016 | $331,000 | +47.8% | 20,053 | +19.6% | 0.00% | – |
| Q3 2016 | $224,000 | +94.8% | 16,761 | -3.5% | 0.00% | – |
| Q2 2016 | $115,000 | -52.1% | 17,377 | -36.2% | 0.00% | – |
| Q1 2016 | $240,000 | +10.6% | 27,237 | +56.7% | 0.00% | – |
| Q4 2015 | $217,000 | -11.1% | 17,377 | 0.0% | 0.00% | – |
| Q3 2015 | $244,000 | – | 17,377 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |